|
1
|
Hildesheim A and Levine PH: Etiology of
nasopharyngeal carcinoma: A review. Epidemiol Rev. 15:466–485.
1993.PubMed/NCBI
|
|
2
|
Geschwind JF, Ko YH, Torbenson MS, Magee C
and Pedersen PL: Novel therapy for liver cancer: Direct
intraarterial injection of a potent inhibitor of ATP production.
Cancer Res. 62:3909–3913. 2002.PubMed/NCBI
|
|
3
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nelson K: 3-Bromopyruvate kills cancer
cells in animals. Lancet Oncol. 3:5242002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Finley RS: Overview of targeted therapies
for cancer. Am J Health Syst Pharm. 60:S4–S10. 2003.
|
|
6
|
Mathupala SP, Ko YH and Pedersen PL:
Hexokinase-2 bound to mitochondria: Cancer's stygian link to the
'Warburg Effect̓ and a pivotal target for effective therapy. Semin
Cancer Biol. 19:17–24. 2009. View Article : Google Scholar :
|
|
7
|
Buchakjian MR and Kornbluth S: The engine
driving the ship: Metabolic steering of cell proliferation and
death. Nat Rev Mol Cell Biol. 11:715–727. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kondoh H: Cellular life span and the
Warburg effect. Exp Cell Res. 314:1923–1928. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakano A, Tsuji D, Miki H, Cui Q, El Sayed
SM, Ikegame A, Oda A, Amou H, Nakamura S, Harada T, et al:
Glycolysis inhibition inactivates ABC transporters to restore drug
sensitivity in malignant cells. PLoS One. 6:e272222011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dolmans DE, Kadambi A, Hill JS, Flores KR,
Gerber JN, Walker JP, Borel Rinkes IH, Jain RK and Fukumura D:
Targeting tumor vasculature and cancer cells in orthotopic breast
tumor by fractionated photosensitizer dosing photodynamic therapy.
Cancer Res. 62:4289–4294. 2002.PubMed/NCBI
|
|
11
|
Peter ME: Programmed cell death: Apoptosis
meets necrosis. Nature. 471:310–312. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Goossens V, Stange G, Moens K, Pipeleers D
and Grooten J: Regulation of tumor necrosis factor-induced,
mitochondria- and reactive oxygen species-dependent cell death by
the electron flux through the electron transport chain complex I.
Antioxid Redox Signal. 1:285–295. 1999. View Article : Google Scholar
|
|
13
|
Trachootham D, Lu W, Ogasawara MA, Nilsa
RD and Huang P: Redox regulation of cell survival. Antioxid Redox
Signal. 10:1343–1374. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Degterev A, Huang Z, Boyce M, Li Y, Jagtap
P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA and Yuan J:
Chemical inhibitor of nonapoptotic cell death with therapeutic
potential for ischemic brain injury. Nat Chem Biol. 1:112–119.
2005. View Article : Google Scholar
|
|
15
|
Declercq W, Vanden Berghe T and
Vandenabeele P: RIP kinases at the crossroads of cell death and
survival. Cell. 138:229–232. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Degterev A, Zhou W, Maki JL and Yuan J:
Assays for necroptosis and activity of RIP kinases. Methods
Enzymol. 545:1–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Humphries F, Yang S, Wang B and Moynagh
PN: RIP kinases: Key decision makers in cell death and innate
immunity. Cell Death Differ. 22:225–236. 2015. View Article : Google Scholar
|
|
18
|
Parlato M, Souza-Fonseca-Guimaraes F,
Philippart F, Misset B, Adib-Conquy M and Cavaillon JM; Captain
Study Group: CD24-triggered caspase-dependent apoptosis via
mitochondrial membrane depolarization and reactive oxygen species
production of human neutrophils is impaired in sepsis. J Immunol.
192:2449–2459. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Galluzzi L and Kroemer G: Necroptosis: A
specialized pathway of programmed necrosis. Cell. 135:1161–1163.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ahmad S and Ansari AA: Therapeutic roles
of heparin anticoagulants in cancer and related disorders. Med
Chem. 7:504–517. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shoshan MC: 3-Bromopyruvate: Targets and
outcomes. J Bioenerg Biomembr. 44:7–15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cardaci S, Desideri E and Ciriolo MR:
Targeting aerobic glycolysis: 3-bromopyruvate as a promising
anticancer drug. J Bioenerg Biomembr. 44:17–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dell'Antone P: Targets of 3-bromopyruvate,
a new, energy depleting, anticancer agent. Med Chem. 5:491–496.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Scarfò L and Ghia P: Reprogramming cell
death: BCL2 family inhibition in hematological malignancies.
Immunol Lett. 155:36–39. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ndubaku C, Varfolomeev E, Wang L, Zobel K,
Lau K, Elliott LO, Maurer B, Fedorova AV, Dynek JN, Koehler M, et
al: Antagonism of c-IAP and XIAP proteins is required for efficient
induction of cell death by small-molecule IAP antagonists. ACS Chem
Biol. 4:557–566. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rossé T, Olivier R, Monney L, Rager M,
Conus S, Fellay I, Jansen B and Borner C: Bcl-2 prolongs cell
survival after Bax-induced release of cytochrome c. Nature.
391:496–499. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kasahara Y, Iwai K, Yachie A, Ohta K,
Konno A, Seki H, Miyawaki T and Taniguchi N: Involvement of
reactive oxygen intermediates in spontaneous and CD95
(Fas/APO-1)-mediated apoptosis of neutrophils. Blood. 89:1748–1753.
1997.PubMed/NCBI
|
|
28
|
De Flora S, Izzotti A, D'Agostini F and
Balansky RM: Mechanisms of N-acetylcysteine in the prevention of
DNA damage and cancer, with special reference to smoking-related
end-points. Carcinogenesis. 22:999–1013. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang CC, Liu TY, Cheng CH and Jan TR:
Involvement of the mitochondrion-dependent pathway and oxidative
stress in the apoptosis of murine splenocytes induced by areca nut
extract. Toxicol In Vitro. 23:840–847. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
de Almagro MC and Vucic D: Necroptosis:
Pathway diversity and characteristics. Semin Cell Dev Biol.
39:56–62. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kaczmarek A, Vandenabeele P and Krysko DV:
Necroptosis: The release of damage-associated molecular patterns
and its physiological relevance. Immunity. 38:209–223. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
He S, Wang L, Miao L, Wang T, Du F, Zhao L
and Wang X: Receptor interacting protein kinase-3 determines
cellular necrotic response to TNF-alpha. Cell. 137:1100–1111. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu X, Chua CC, Kong J, Kostrzewa RM,
Kumaraguru U, Hamdy RC and Chua BH: Necrostatin-1 protects against
glutamate-induced glutathione depletion and caspase-independent
cell death in HT-22 cells. J Neurochem. 103:2004–2014. 2007.
View Article : Google Scholar : PubMed/NCBI
|
